Asia-Pacific colorectal screening score and colorectal cancer screening in asymptomatic Asian population.

Authors

null

Joseph JY Sung

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, Hong Kong

Joseph JY Sung , Hyun S Kim , Khean Lee Goh , Jose Sollano , Khay Guan Yeoh , Han Mo Chiu , Deng Chiang Wu , Rungsun Rerknimitr , Takahisa Matsuda , Vui Heng Chong , Furqaan Ahmed , Jingnan Li , Rupert Leong , Kelvin KF Tsoi , Martin CS Wong

Organizations

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, Hong Kong, Asia Pacific Working Group on Colorectal Cancer, South Korea, South Korea, Asia Pacific Working Group on Colorectal Cancer, Malaysia, Malaysia, Asia Pacific Working Group on Colorectal Cancer, Philippines, Philippines, Asia Pacific Working Group on Colorectal Cancer, Singapore, Singapore, Asia Pacific Working Group on Colorectal Cancer, Taiwan, Taiwan, Asia Pacific Working Group on Colorectal Cancer, Thailand, Thailand, National Cancer Center Hospital, Tokyo, Japan, Asia Pacific Working Group on Colorectal Cancer, Brunei, Brunei, Asia Pacific Working Group on Colorectal Cancer, Pakistan, Pakistan, Asia Pacific Working Group on Colorectal Cancer, China, China, Asia Pacific Working Group on Colorectal Cancer, Australia, Australia, School of Public Health, The Chinese University of Hong Kong, Hong Kong, Hong Kong

Research Funding

No funding sources reported

Background: There has been a rapid rise in colorectal cancer (CRC) incidence in recent decades in many Asian countries. Age, gender, smoking, and family history are the significant risk factors of CRC. This study would like to develop an Asia-Pacific Colorectal Screening (APCS) score to identify subjects with high-risk for colorectal advanced neoplasia (AN) in Asia. Methods: A multicentre study was in 11 Asian cities. A total of 7,463 asymptomatic subjects underwent screening colonoscopy. The first 2,000 subjects were used as a derivation cohort. AN was defined as advanced adenoma and CRC. A multiple logistic regression was applied to the derivation cohort identifying significant risk factors for AN; odds ratios of significant risk factors were then utilized to develop APCS score ranging from 0-6, including age (0=40-49, 1=50-59, 2=60+), gender (0=female, 1=male), family history (0=absent, 1=present), smoking (0=no, 1=current or past), and Body Mass Index (BMI) (0= <23kg/m2, 1= >23kg/m2). Three tiers of risk were defined: 0 ‘average risk’ (AR); 1-3 ‘moderate risk’ (MR); and 4–6 ‘high risk’ (HR). The APCS score was applied to the validation cohort as performance assessment. Results: The baseline prevalence of AN were 4.9% and 5.4% in the derivation and validation cohorts. In the validation cohort, 110 subjects (2.0%) were in AR, 4,148 subjects (75.9%) in MR, and 1,205 (22.1%) subjects in HR. Prevalence of AN in AR, MR and HR were 0.9%, 4.1% and 10.5% respectively. Compared with AR, subjects in MR and HR had 4.5-fold and 11.5-fold increased prevalence of AN. Conclusions: The APCS score based on age, gender, family history, smoking and BMI is a useful tool in stratifying asymptomatic Asians for priority of CRC screening.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 3545)

DOI

10.1200/jco.2014.32.15_suppl.3545

Abstract #

3545

Poster Bd #

8

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Annual Meeting

Cost effectiveness of colorectal cancer screening in the Dominican Republic.

First Author: Yoanna S. Pumpalova

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Trends in colorectal cancer screening from NHIS survey: Analysis of modalities impact on overall screening.

First Author: Derek W. Ebner

First Author: Shai Friedland

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Impact of revising colorectal cancer screening guidelines on health care resources in Canada.

First Author: Brendan Chia